Vr Adviser, LLC Lian Bio Transaction History

Vr Adviser, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$1.57 - $2.66 $7.53 Million - $12.7 Million	-4,793,047 Closed	0 $0
Q4 2022 May 15, 2023	SELL	$1.14 - $2.11 $667,235 - $1.23 Million	-585,294 Reduced 10.88%	4,793,047 $7.86 Million
Q4 2022 Feb 14, 2023	SELL	$1.14 - $2.11 $667,235 - $1.23 Million	-585,294 Reduced 10.88%	4,793,047 $7.86 Million
Q2 2022 May 15, 2023	BUY	$2.15 - $6.01 $1.26 Million - $3.52 Million	585,294 Added 12.21%	5,378,341 $11.6 Million
Q4 2021 Feb 14, 2022	BUY	$6.14 - $16.2 $33 Million - $87.1 Million	5,378,341 New	5,378,341 $33.1 Million

1.1M

Ticker LIAN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 108,354,000
Market Cap $32.5M
Description
LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with p...

Get notified when there are updates to the investment portfolio of Vr Adviser, LLC, based on Form 13F filings with the SEC.

Stay updated on Vr Adviser, LLC with notifications on news.